MEDICAL DEVICE ALLIANCE INC
NT 10-Q, 2000-11-15
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: BRADLEY OPERATING L P, 15-12G, 2000-11-15
Next: CANADIAN NORTHERN LITES INC, 10QSB, 2000-11-15



<PAGE>


                                     UNITED STATES
                          SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C. 20549

                                      FORM 12b-25

                              NOTIFICATION OF LATE FILING

(CHECK ONE):  [ ]Form 10-K [ ]Form 20-F [ ]Form 11-K
              [X]Form 10-Q [ ]Form N-SAR

                           For Period Ended: September 30, 2000

[ ] Transition Report on Form 10-K    [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F    [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K

         For the Transition Period Ended:


Read attached instruction before preparing form.
Please print or type.

         Nothing in this form shall be construed to imply that the commission
has verified any information contained herein.

         If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:


                                    PART I
                             REGISTRANT INFORMATION


Full Name of Registrant:  Medical Device Alliance, Inc.
Former Name if Applicable:  N/A
Address of Principal Executive Office (Street and Number):  5851 West Charleston
City, State and Zip Code:  Las Vegas, Nevada 89146


                                   PART II
                            RULES 12b-25(b) AND (c)


If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)

[X]      (a)  The reasons described in reasonable detail in Part III of this
         form could not be eliminated without unreasonable effort or
         expense;
[ ]      (b)  The subject annual report, semi-annual report, transition report
         on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof,
         will be filed on or before the 15th calendar day following the
         prescribed due date; or the subject quarterly report or transition
         report on Form 10-Q, or portion thereof will be filed on or before
         the fifth calendar day following the prescribed due date; and


<PAGE>


[ ]      (c)  The accountant's statement or other exhibit required by
         Rule 12b-25(c) has been attached if applicable.


                                  PART III
                                  NARRATIVE


State below in reasonable detail the reasons why Forms 10-K, 11-K, 20-F, 10-Q,
N-SAR, or the transition report or portion thereof could not be filed within
the prescribed time period. (Attach extra sheets if needed.)

         As previously reported on Form 8-K, the District Court of Clark
County, Nevada (the "COURT") appointed George C. Swarts as receiver (the
"RECEIVER") over all of the day-to-day administration and management of the
Company and its assets. As a result of on-going complications related to the
Receivership, the Company has not been able to complete the preparation of
its financial statements for the years ended December 31, 1998 and December
31, 1999, and for the interim periods ended March 31, June 30, and September
30, 1999, March 31, 2000, June 30, 2000, and September 30, 2000, or to
complete the audit of its year end 1998 and 1999 financial statements. Until
the Company can complete the preparation and audit of its financial
statements, the Company will continue to be unable to file its Form 10-KSBs
and Form 10-QSBs for such respective periods, and will therefore remain in
non-compliance with its reporting obligations under the Exchange Act. The
Company is continuing to work diligently with its auditors to finalize its
financial statements and complete the year end audits as soon as reasonably
practicable, however, given its current financial and other constraints,
combined with the inability to predict the results of the Receiver's on-going
diligence investigation, the Company is unable at this time to determine with
any degree of certainty when it expects to be in full compliance with its
reporting obligations under the Exchange Act.


                                   PART IV
                              OTHER INFORMATION


(1) Name and telephone number of person to contact in regard to this
    notification

    George C. Swarts          (702)               870-8663
        (Name)             (Area Code)        (Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the
    Securities Exchange Act of 1934 or Section 30 of the Investment Company
    Act of 1940 during the preceding 12 months or for such shorter period
    that the registrant was required to file such report(s) been filed?

    If answer is no, identify report(s).
                                         [ ] Yes  [X] No

    Forms 10-KSB for the years ended December 31, 1998 and December 31, 1999,
and Form 10-QSBs for the quarters ended March 31, June 30, September 31,
1999, March 31, 2000, June 30, 2000, and September 30, 2000 (See Part III).

(3) Is it anticipated that any significant change in results of operations
    from the corresponding period for the last fiscal year will be reflected
    by the earnings statements to be included in the subject report or
    portion thereof?
                                         [ ] Yes  [X] No


<PAGE>


    If so, attach an explanation of the anticipated change, both narratively
    and quantitatively, and, if appropriate, state the reasons why a reasonable
    estimate of the results cannot be made.

                                      MEDICAL DEVICE ALLIANCE INC.
                               (Name of Registrant as Specified in Charter)

    Has caused this notification to be signed on its behalf by the undersigned
    hereunto duly authorized.


    Date:  November 15, 2000             By:  /s/ George C. Swarts, Receiver



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission